A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

In animal studies, brain tumors nearly disappeared when an experimental drug, MT-125, was given as a combo with an oncology drug that otherwise does not work on aggressive glioblastoma. The U.S. Food ...

A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Scientists from UCSD’s Sanford Stem Cell Institute are working in collaboration with Axiom Space and the JM Foundation on the ...

Cell and gene therapy leaders say the agency’s decision to remove the Risk Evaluation and Mitigation Strategies that had been ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

After several years of development, Processa Pharmaceuticals has determined that the nearest milestone for anticancer asset ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...